《大行報告》里昂下調信義光能(00968.HK)目標價至9.5元 評級「買入」
里昂發表報告指,信義光能(00968.HK)成本控制令人失望,以及上游項目可能造成盈利稀釋,影響投資者看法。不過,該行認為8月份太陽能玻璃價格會因新增產能放緩和全行業去庫存化而回升。
鑒於政策收緊趨勢,該行估計太陽能玻璃季度供需比例將從年初的1.57降至第四季的0.94,顯示第四季可能出現供應緊張。
由於信義光能上半年業績未達預期,里昂將今年淨利潤預測下調31.3%,並將目標價由12.8元下調至9.5元。維持「買入」評級,相信成本波動已經過去,而且公司應受惠於下半年行業動態改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.